Literature DB >> 6187933

Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.

M Aboud, Y Hassan.   

Abstract

Interferon treatment of NIH 3T3 cells chronically infected with Moloney murine leukemia virus inhibited about 95% of virus release. This inhibition was accompanied by a three- to twofold accumulation of intracellular virions. However, this accumulation could be demonstrated only be exogenous reverse transcriptase reaction assay or radioactive labeling of the assembled viral proteins. It could not be shown by the endogenous reverse transcriptase reaction assay, which depended on endogenous viral RNA, or by labeling the encapsidated viral RNA. It was therefore evident that most of the intracellular virions accumulated in interferon-treated cells were RNA deficient. Hybridization analysis revealed that these virions were deficient of genomic viral RNA, whereas size analysis by gel electrophoresis suggested that the deficiency of 4S RNA normally packaged in Moloney murine leukemia virus was even stronger. Our data also suggested that this RNA deficiency was not due to degradation of the encapsidated RNA, but more likely to a defect in virus assembly. RNA-lacking intracellular virions were unstable; they were found to collapse before being released.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6187933      PMCID: PMC256441     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  Trapping of oncornavirus particles at the surface of interferon-treated cells.

Authors:  A Billiau; H Heremans; P T Allen; J De Maeyer-Guignard; P De Somer
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

2.  Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. IV. Relevance to the potential application of interferon in natural infectious diseases.

Authors:  A Billiau; H Heremans; P T Allen; P De Somer
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

3.  Erythrocyte membrane-specific antigens in Friend virus-induced leukemia cells.

Authors:  Y Ikawa; M Furusawa; H Sugano
Journal:  Bibl Haematol       Date:  1973

4.  Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release.

Authors:  A Billiau; V G Edy; H Sobis; P de Somer
Journal:  Int J Cancer       Date:  1974-09-15       Impact factor: 7.396

5.  Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.

Authors:  J G Levin; P M Grimley; J M Ramseur; I K Berezesky
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

6.  Enhancement of erythrocytic maturation of Friend virus-induced leukemia cells in vivo.

Authors:  H Sugano; M Furusawa; T Kawaguchi; Y Ikawa
Journal:  Bibl Haematol       Date:  1973

7.  Coating of Friend leukemia virus after treatment with specific antiserum.

Authors:  T Sato; C Friend; C Stackpole; E De Harven
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

8.  Ultrastructural changes in Friend erythroleukemia cells treated with dimethyl sulfoxide.

Authors:  T Sato; C Friend; E De Harven
Journal:  Cancer Res       Date:  1971-10       Impact factor: 12.701

9.  Origin of the viremia in murine leukemia.

Authors:  E De Harven; C Friend
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

10.  An electron microscopic study of a virus-induced murine sarcoma (Moloney).

Authors:  A J Dalton
Journal:  Natl Cancer Inst Monogr       Date:  1966-09
View more
  4 in total

Review 1.  Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.

Authors:  E G Sandström; J C Kaplan
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

2.  Purification, thioredoxin renaturation, and reconstituted activity of the three subunits of the influenza A virus RNA polymerase.

Authors:  B Szewczyk; W G Laver; D F Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

3.  Persistent expression of v-mos oncogene in transformed cells that revert to nonmalignancy after prolonged treatment with interferon.

Authors:  D Sergiescu; J Gerfaux; A M Joret; C Chany
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor.

Authors:  I Maillard; P Launois; I Xenarios; J A Louis; H Acha-Orbea; H Diggelmann
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.